2012 GI Cancers Symposium – Advancements in the Colorectal Cancer Landscape
For the ninth year oncologists, researchers, patient advocates and health professionals recently gathered in San Francisco at the Gastrointestinal (GI) Cancers Symposium. The three-day multidisciplinary meeting focused on discussing major developments and strategies in preventing, screening and treating GI cancers. At this year’s meeting, important advances in research and emerging therapies for GI cancers were revealed, including a novel stool DNA test for colorectal cancer (CRC) screening, a blood test to detect early-stage pancreatic cancer and a new targeted therapy that may help extend the lives of CRC patients, among others.
In addition to notable research, the formation of a new global patient advocacy organization was unveiled – the Global Colon Cancer Alliance (GCCA). The alliance unites the U.S.-based Colon Cancer Alliance and European-based EuropaColon. With few global colon cancer efforts of this kind, it will be interesting to monitor how the emergence of this international alliance will affect the patient advocacy landscape and the impact this new effort may have for CRC patients.
You can find out more about news coming out the GI Cancer Symposium from the meeting’s news page or on Twitter via #GI12.